LI-COR Image Studio Lite 4.0 Software – Installation on Windows Systems – Video

Posted on by


LI-COR Image Studio Lite 4.0 Software - Installation on Windows Systems
This video gives instructions for the basic to install Image Studio Lite 4.0 on a Windows system. Next video in the series: ** Create a Work Area - http://yo...

By: LI-COR Biosciences Biotechnology

See the original post here:
LI-COR Image Studio Lite 4.0 Software - Installation on Windows Systems - Video

Image Studio 4.0 for C-DiGit Scanner – Installation on Windows Systems – Video

Posted on by


Image Studio 4.0 for C-DiGit Scanner - Installation on Windows Systems
This video tutorial walks through the basic steps to install Image Studio on a Windows system for the C-DiGit Blot Scanner. Next video in the series: ** Crea...

By: LI-COR Biosciences Biotechnology

Read more here:
Image Studio 4.0 for C-DiGit Scanner - Installation on Windows Systems - Video

LI-COR Image Studio 4.0 Software for Odyssey Sa and Aerius Systems – Image Acquisition – Video

Posted on by


LI-COR Image Studio 4.0 Software for Odyssey Sa and Aerius Systems - Image Acquisition
This video tutorial demonstrates the Acquire tab, which contains all of the controls for acquiring new images with Image Studio 4.0 Software on the Odyssey S...

By: LI-COR Biosciences Biotechnology

View post:
LI-COR Image Studio 4.0 Software for Odyssey Sa and Aerius Systems - Image Acquisition - Video

LI-COR Image Studio 4.0 Software – MPX Western Analysis Ribbon for Multiplex Western Blots – Video

Posted on by


LI-COR Image Studio 4.0 Software - MPX Western Analysis Ribbon for Multiplex Western Blots
This video tutorial demonstrates the Image Studio 4.0 MPX Western Analysis Ribbon and the tools provided to analyze a multiplexed Western blot performed with...

By: LI-COR Biosciences Biotechnology

Read the original here:
LI-COR Image Studio 4.0 Software - MPX Western Analysis Ribbon for Multiplex Western Blots - Video

LI-COR Image Studio 4.0 Software for Odyssey Classic – Image Acquisition – Video

Posted on by


LI-COR Image Studio 4.0 Software for Odyssey Classic - Image Acquisition
This video tutorial demonstrates the Acquire Ribbon, which contains all of the controls for acquiring new images with Image Studio 4.0 Software on the Odysse...

By: LI-COR Biosciences Biotechnology

More here:
LI-COR Image Studio 4.0 Software for Odyssey Classic - Image Acquisition - Video

Biotechnology Careers | Biotechnology Degrees

Posted on by

A degree in biotechnology is not a one way ticket into a lab coat. An education in biotechnology can set you up for a wide variety of careers including management, marketing, and of course, laboratory science. Your career in biotechnology is really dependent on your highest level of education you have achieved. Below you will find a comprehensive view of the career potential of a biotechnology graduate at all levels - associates, bachelors, masters, and doctorate.

We provide the average salary from multiple credible data sources the BLS and Simply Hired as well as the degrees required to obtain employment in the biotechnology careers listed. Simply click into one of the careers to view all of the information.

Bioinformaticians enjoy one of the most challenging areas of biotechnology. They are required to have highly advanced knowledge of both biology and computer science.

This use information technology and computer science skills in order to take biomedical data and create useful information. You have probably heard of the effort to map the human genome. This is made possible because of the skills utilized by a bioinformatician.

Biomedical Engineers use knowledge of engineering, biology, and he medical field to develop new tools and products that better the lives of patients. They often undertake research products with scientists from other fields, engineers or business professionals to develop these products. Biomedical engineers develop products such as prostheses (artificial limbs), artificial organs, information systems, and imaging systems.

Biomedical engineering also involves developing products for inside the body as well. This includes devices for regulating heart beat or insulin. At the leading edge of this area of biomedical engineering is bionics. The development of something like the Terminator would require a lot of help from biomedical engineers. For graduates not interested in the lab, sales offers a lot of benefits for the right person. Professional salespeople with a background in biotechnology enjoy high salaries and a fast paced work environment. Companies selling biotechnology products or pharmaceuticals often place a premium on candidates with both sales talent and a solid knowledge of the field. A biotechnology degree allows a salesperson to converse with and understand their customers in a way other sales people cant.

Unfortunately the BLS does not have a specific job title and career description for this unique position. The growth of the biotechnology industry means that students dont need a Ph.D or masters degree to enter the field. Many Biotechnology Laboratory Technicians have an Associates degree or certificate and are an extremely important, and growing portion of the biotechnology job market.

The biotechnology laboratory technicians primary responsibility is to assist other scientists and the tasks that they perform vary greatly. Laboratory technicians may monitor and set up instruments, check on and record test results and other basic tasks. In manufacturing settings, they often are in charge of monitoring parts of the process for quality and accuracy. A research associate is responsible for research and development in collaboration with others on projects. He or she makes detailed observations, analyzes data, and interprets results. Research associates prepare technical reports, summaries, protocols, and quantitative analyses. An incumbent maintains familiarity with current scientific literature and contributes to the process of a project within his or her scientific discipline, as well as investigating, creating, and developing new ethods and technologies for project advancement. He or she may also be responsible for identifying patentable inventions and acting as principal investigator in conducting his or her own experiments. A research associate may also be asked to participate in scientific conferences and contribute to scientific journals.

The BLS equivalent for this career is a Biological Technician. A clinical research associate is responsible for the design, planning, implementation, and overall direction of clinical research projects. He or she evaluates and analyzes clinical data and coordinates activities of associates to ensure compliance with protocol and overall clinical objectives. He or she may also travel to field sites to supervise and coordinate clinical studies. An entry-level clinical research associate position typically requires a bachelor of science, a registered nurse degree or equivalent, and a minimum of 0 to 2 years clinical experience in medical research, nursing, or the pharmaceutical industry. Knowledge of FDA regulatory requirements is also preferred.

The most similar position the Bureau of Labor Statistics lists is Medical and Clinical Laboratory Technologists and Technicians. Crime Lab Technicians live at the intersection of criminal justice and science. They use their knowledge of science to assist law enforcement in making decisions about cases. This field growing in importance and is what makes the difference in many modern criminal cases.

People with a knowledge of biotechnology and biology can give much needed assistance to law enforcement. Many cases require the ability to determine who a strand of hair or spot of blood belong to. Employees with a background in biology and biotechnology are well prepared to provide this chemical and physical analysis.

The BLS equivalent for this career is a Forensic Science Technician. Environmental engineers combine engineering science, biology, and data to solve issues for the environment, which creates obvious crossover with the biotechnology industry. Many biotechnology engineers work in the environmental engineering field.

As with most higher level engineering positions, a degree is typically required. Most environmental engineers have bachelors degrees, and some obtain their masters or above degree. There are also steps for obtaining licensing, such as the PE exam (Professional Engineer), set by the National Society of Professional Engineers.The Quality Control Analyst performs analysis of ingredients to ensure everything is operating according to specifications.

They run tests, collect data, and review data obtained for compliance with specifications, to be sure that processes and products meet with company and industry approval. If anything out of the ordinary is discovered, they report it. They also make changes to the organizations operating procedures.

The BLS equivalent is Quality Control Inspector. The Quality Control Engineer manages the quality systems that go into the product development process. They design the inspection and testing that go into ensuring that the product is developed according to specifications.

The BLS equivalent is an industrial engineer. Senior Researchers often work in a college or university setting, but more and more these talented scientists hold top positions in the R & D departments of biotech companies. As more biotechnology companies spring up, the demand for this level of skill will continue to increase. Many Senior Researchers are specialist in a few areas of biotechnology. The high level knowledge needed at this level requires specialization.

Within the corporate setting, the Seniors Researcher is responsible for the direction of the research, the quality of the experiments, the management of assistants and associates, and ultimately, the viability of the product produced. They also participates in the development of patent applications, and may be responsible for managing the developing of a research group.

The BLS equivalent for this specific career title is Computer and Information Research Scientist. Validation Technicians are an important part of the biotechnology manufacturing process. This is an entry level position that helps to ensure quality products are being manufactured. They make sure that products comply with all regulatory and safety rules established by outside agencies, laws and within the company. To accomplish this, they gather validation data and analyze the data to make sure that the process in place results in a standards compliant product.

Validation Technicians may also help with troubleshooting and making suggestions of ways to improve processes.

BLS Sources:Biochemists and BiophysicistsBiological TechniciansMedical and Clinical Laboratory TechniciansQuality Control InspectorsComputer & IT Information Research ScientistsBiomedical EngineersForensic Science TechniciansEnvironmental EngineersBureau of Labor Statistics

At Biotechnology Degree Guide, we mostly focus on helping people interested in getting into biotechnology to find a degree, so most of our dealing and knowledge is with education and different degree paths. We do not currently have any featured relationships with any companies hiring anyone within biotechnology, but we have provided a resource of links below just in case you are looking for a job.

ActionBioScience.orgAmerican Society of Plant BiologistsAmerican Society for MicrobiologyBio.orgBioHealthRxBioJobNetBiojobnetworkBiocomBiocom WorkforceBio-LinkBioSpaceBiotechnology Jobs in Seattle WashingtonChemistry.orgEisenhower National Clearinghouse for Mathematics and Science EducationHire HealthLifeWorksLinkedIn Biotech JobsMedzillaNASA Kids Science News NetworkNature JobsNIH CareersPharma opportunities Biotech JobsScience JobsTiny Tech JobsBiotechnology Jobs in CaliforniaVaultWet Feet

Here is the original post:
Biotechnology Careers | Biotechnology Degrees

Hans Schikan, CEO of Prosensa, on Rare Disease Drug Development – Video

Posted on by


Hans Schikan, CEO of Prosensa, on Rare Disease Drug Development
At the BIO CEO Investor Conference in New York, BIO had the opportunity to speak with Hans Schikan, CEO of Prosensa, a company that targets rare diseases -...

By: Biotechnology Industry Organization

Read more from the original source:
Hans Schikan, CEO of Prosensa, on Rare Disease Drug Development - Video

Biotechnology – Miami Dade College

Posted on by

Prepare for a cutting-edge career with a bachelor's degree in biological sciences from Miami Dade College. South Florida is home to two major life sciences research hubs and more than 1,300 companies that are creating the future right now and have a high demand for skilled workers. This program responds to the needs of our regions employers.

A capstone internship with a prospective employer or private/public partner moves beyond the classroom, allowing you to put your skills to the test in the real world.

The biotechnology concentration of this bachelors program helps you build the knowledge and skills youll need to succeed in the life sciences. As a biotechnology student, youll learn about:

Continued growth in the biotechnology and medical research fields is expected to continue to drive growth in the life sciences industry, especially in the South Florida region, which is rapidly evolving into a hot spot for life sciences research. An education in biotechnology opens doors to careers in a variety of workplaces, including:

These four-year programs combine extensive academic studies with the real-world experience students need to pursue a career in their selected field.

Read more from the original source:
Biotechnology - Miami Dade College

Two Biotechnology Names Are Hot: Merrimack Pharmaceuticals, Inc. (MACK), MannKind Corporation (MNKD) – The Independent Republic

Posted on by

Merrimack Pharmaceuticals, Inc. (MACK) ended last trading session with a change of 0.96 percent. It trades at an average volume of 4.05M shares versus 1.35M shares recorded at the end of last trading session. The share price of $3.17 is at a distance of 12.01 percent from its 52-week low and down -64.86 percent versus its peak. The company has a market cap of $399.07M and currently has 125.89M shares outstanding. The share price is currently 0.08 percent versus its SMA20, -26.55 percent versus its SMA50, and -41.42 percent versus its SMA200. The stock has a weekly performance of 3.59 percent and is -22.3 percent year-to-date as of the recent close.

On Jan. 18, 2017 Merrimack Pharmaceuticals, Inc. (MACK) announced that Richard Peters, M.D., Ph.D., has been appointed as the Companys President and Chief Executive Officer, effective February 6, 2017, at which time he will also be appointed to the Merrimack Board of Directors. Dr. Peters will join Merrimack from his current role at Sanofi Genzyme, where he serves as Senior Vice President and Head of Global Rare Diseases. He replaces Gary Crocker, Chairman and Interim President and CEO, who guided the Company during the recent restructuring process and search for a permanent CEO and will remain Chairman of the Board.

MannKind Corporation (MNKD) recently recorded -4.25 percent change and currently at $0.54 is 31.98 percent away from its 52-week low and down -75.84 percent versus its peak. It has a past 5-day performance of -15.76 percent and trades at an average volume of 5.54M shares. The stock has a 1-month performance of -17.78 percent and is -15.01 percent year-to-date as of the recent close. There were about 498.94M shares outstanding which made its market cap $269.98M. The share price is currently -17.65 percent versus its SMA20, -15.12 percent versus its SMA50, and -34.44 percent versus its SMA200.

Feb. 01, 2017 MannKind Corporation (MNKD), a fully integrated biopharmaceutical company focusing on the discovery and development of therapeutic products for patients with diseases such as diabetes, announced the launch of a new Titration Pack containing 60 4 unit cartridges, 60 8 unit cartridges and 60 12 unit cartridges of Afrezza (insulin human) Inhalation Powder.

This new package is intended to simplify physician prescribing of Afrezza and allow patients greater dose flexibility in managing their diabetes, while potentially reducing the cost burden of multiple copays.

Go here to read the rest:
Two Biotechnology Names Are Hot: Merrimack Pharmaceuticals, Inc. (MACK), MannKind Corporation (MNKD) - The Independent Republic

The State Street Corp Acquires 1032915 Shares of Puma Biotechnology Inc (PBYI) – Petro Global News 24

Posted on by

State Street Corp raised its stake in shares of Puma Biotechnology Inc (NYSE:PBYI) by 113.1% during the fourth quarter, Holdings Channel reports. The fund owned 1,946,098 shares of the biopharmaceutical companys stock after buying an additional 1,032,915 shares during the period. State Street Corp owned about 0.05% of Puma Biotechnology worth $59,746,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. BlackRock Advisors LLC raised its position in Puma Biotechnology by 289.2% in the third quarter. BlackRock Advisors LLC now owns 54,120 shares of the biopharmaceutical companys stock valued at $3,629,000 after buying an additional 40,214 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in Puma Biotechnology by 2.4% in the third quarter. UBS Asset Management Americas Inc. now owns 12,891 shares of the biopharmaceutical companys stock valued at $864,000 after buying an additional 300 shares during the last quarter. CAM Group Holding A S acquired a new position in Puma Biotechnology during the third quarter valued at approximately $2,012,000. Bank of New York Mellon Corp raised its position in Puma Biotechnology by 41.6% in the third quarter. Bank of New York Mellon Corp now owns 158,443 shares of the biopharmaceutical companys stock valued at $10,623,000 after buying an additional 46,525 shares during the last quarter. Finally, Smith Asset Management Group LP acquired a new position in Puma Biotechnology during the third quarter valued at approximately $371,000. 80.98% of the stock is owned by institutional investors and hedge funds.

Shares of Puma Biotechnology Inc (NYSE:PBYI) opened at 41.80 on Wednesday. Puma Biotechnology Inc has a one year low of $19.74 and a one year high of $73.27. The company has a 50-day moving average of $35.92 and a 200 day moving average of $43.82. The firms market cap is $1.54 billion.

Puma Biotechnology (NYSE:PBYI) last posted its quarterly earnings data on Wednesday, March 1st. The biopharmaceutical company reported ($2.04) EPS for the quarter, missing the Zacks consensus estimate of ($1.92) by $0.12. On average, equities research analysts expect that Puma Biotechnology Inc will post ($8.32) EPS for the current fiscal year.

Several research analysts have recently commented on the stock. Stifel Nicolaus reissued a buy rating and issued a $88.00 price objective on shares of Puma Biotechnology in a research note on Wednesday, November 30th. Royal Bank of Canada reissued a sector perform rating on shares of Puma Biotechnology in a research note on Wednesday, November 16th. Cowen and Company reissued a market perform rating on shares of Puma Biotechnology in a research note on Tuesday, November 15th. Credit Suisse Group AG reissued an outperform rating and issued a $111.00 price objective on shares of Puma Biotechnology in a research note on Tuesday, November 15th. Finally, Zacks Investment Research lowered shares of Puma Biotechnology from a buy rating to a hold rating in a research note on Tuesday, January 10th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the companys stock. The stock currently has an average rating of Hold and an average target price of $73.50.

In other news, SVP Richard Paul Bryce sold 2,293 shares of the companys stock in a transaction dated Friday, January 20th. The shares were sold at an average price of $33.24, for a total transaction of $76,219.32. Following the completion of the transaction, the senior vice president now owns 29,237 shares of the companys stock, valued at approximately $971,837.88. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Robert Charnas sold 3,008 shares of the companys stock in a transaction dated Wednesday, February 1st. The shares were sold at an average price of $31.83, for a total transaction of $95,744.64. Following the transaction, the insider now directly owns 28,461 shares of the companys stock, valued at approximately $905,913.63. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,503 shares of company stock valued at $511,078. Corporate insiders own 22.70% of the companys stock.

About Puma Biotechnology

Puma Biotechnology, Inc is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on in-licensing the global development and commercialization rights to over three drug candidates, including PB272 (neratinib (oral)), which the Company is developing for the treatment of patients with human epidermal growth factor receptor type 2 (HER2), positive breast cancer, and patients with non-small cell lung cancer, breast cancer and other solid tumors that have a HER2 mutation; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of patients with advanced cancer, and PB357, which is an orally administered agent.

Want to see what other hedge funds are holding PBYI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Puma Biotechnology Inc (NYSE:PBYI).

See the original post here:
The State Street Corp Acquires 1032915 Shares of Puma Biotechnology Inc (PBYI) - Petro Global News 24